Innovation Pharmaceuticals Inc (IPIX)

[rule_rationale]

I think that what they do know is that pumping in Kevetrin at extremely high doses once a week is not advantageous based upon the pharmacodynamic analyses they have performed. The investigators have realized that maintaining concentrations in the bloodstream for extended periods is what patients need and a smaller dose more times per week will accomplish this. It is a waist of time and resources to continue the current protocol - time for phase 2 trials with better dosing regimines knowing what they know now with Phase 1 data in hand. People need to stop thinking in straight lines.